` Comparison: 3G6 vs CYTH - Alpha Spread

3G6
vs
CYTH

Over the past 12 months, 3G6 has outperformed CYTH, delivering a return of -17% compared to the CYTH's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
3G6
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

3G6 Intrinsic Value
25.03 EUR
Undervaluation 49%
Intrinsic Value
Price
CYTH Intrinsic Value
326.76 USD
Undervaluation 70%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
GNI Group Ltd
XBER:3G6
12.8 EUR
Cyclo Therapeutics Inc
NASDAQ:CYTH
99 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
3G6, CYTH

3G6
CYTH
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
GNI Group Ltd
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
3G6, CYTH

3G6
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
GNI Group Ltd
XBER:3G6
Cyclo Therapeutics Inc
NASDAQ:CYTH
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

3G6
74.5%
CYTH
91.2%

Operating Margin

3G6
-13%
CYTH
-2 834.1%

Net Margin

3G6
-16.4%
CYTH
-2 848.2%

FCF Margin

3G6
-14.8%
CYTH
-2 586.1%

ROE

3G6
-10.2%
CYTH
341.5%

ROA

3G6
-5.7%
CYTH
-457.1%

ROIC

3G6
-10.2%
CYTH
1 154.9%

ROCE

3G6
-5.2%
CYTH
340.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
3G6, CYTH

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
3G6, CYTH

Loading
3G6
CYTH
Difference
www.alphaspread.com

Performance By Year
3G6, CYTH

Loading
3G6
CYTH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 3G6 to other stocks
PNEXF
Pharnext SCA
More expensive
vs 3G6
ABBV
Abbvie Inc
More expensive
vs 3G6
AMGN
Amgen Inc
More expensive
vs 3G6
GILD
Gilead Sciences Inc
More expensive
vs 3G6
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett